Bremer, B. Et Al. 2021. Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study. LIVER INTERNATIONAL , vol.41, no.2 , 295-299.

Bremer, B., Anastasiou, O. E., Hardtke, S., Caruntu, F. A., Curescu, M. G., Yalçın, K., ... Akarca, U. S.(2021). Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study. LIVER INTERNATIONAL , vol.41, no.2, 295-299.

Bremer, Birgit Et Al. "Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study," LIVER INTERNATIONAL , vol.41, no.2, 295-299, 2021

Bremer, Birgit Et Al. "Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study." LIVER INTERNATIONAL , vol.41, no.2, pp.295-299, 2021

Bremer, B. Et Al. (2021) . "Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study." LIVER INTERNATIONAL , vol.41, no.2, pp.295-299.

@article{article, author={Birgit Bremer Et Al. }, title={Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study}, journal={LIVER INTERNATIONAL}, year=2021, pages={295-299} }